Motilal Oswal S&P BSE Healthcare ETF - Growth - Regular Plan

Other Plans and Options
  • 0.72 %Nav, as on 02-06-2023

  • Previous Nav

  • Net Change on 02-06-2023

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 4.37 11.05 8.96 15.69 13.96 13.31

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 12.99 24.79 12.78 0.07 149,735.01
SBI S&P BSE SENSEX ETF Mar 15, 2013 13.99 24.72 13.39 0.07 88,067.31
Nippon India ETF Nifty 50 BeES Dec 28, 2001 13.01 24.81 12.82 0.04 12,359.15
Nippon India ETF Nifty Bank BeES May 27, 2004 23.71 30.39 10.40 0.19 6,064.46
ICICI Prudential Nifty 50 ETF Mar 20, 2013 13.03 24.81 12.80 0.03 5,213.15

Fund Holdings as on 30-April-2023

  • Sun Pharmaceutical Industries Limited

  • Dr. Reddy's Laboratories Limited

  • Cipla Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Aurobindo Pharma Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Fortis Healthcare Limited

  • Zydus Lifesciences Limited

  • Laurus Labs Limited

  • Abbott India Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Gland Pharma Limited

  • Syngene International Limited

  • Glenmark Pharmaceuticals Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Dr. Lal Path Labs Limited

  • Pfizer Limited

  • Natco Pharma Limited

  • Krishna Institute Of Medical Sciences Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Sanofi India Limited

  • Narayana Hrudayalaya Limited

  • Ajanta Pharma Limited

  • Suven Pharmaceuticals Limited

  • Poly Medicure Limited

  • Aster DM Healthcare Limited

  • Granules India Limited

  • Piramal Pharma Limited

  • Procter & Gamble Health Limited

  • Metropolis Healthcare Limited

  • Alembic Pharmaceuticals Limited

  • Global Health Limited

  • Jubilant Pharmova Limited

  • Rainbow Childrens Medicare Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • Net Receivables / (Payables)

  • Eris Lifesciences Limited

  • Neuland Laboratories Limited

  • Vijaya Diagnostic Centre Limited

  • Marksans Pharma Limited

  • Caplin Point Laboratories Limited

  • FDC Limited

  • Sun Pharma Advanced Research Company Limited

  • Aarti Drugs Limited

  • Unichem Laboratories Limited

  • Indoco Remedies Limited

  • Hikal Limited

  • Glenmark Life Sciences Limited

  • Healthcare Global Enterprises Limited

  • Ami Organics Limited

  • Advanced Enzyme Technologies Limited

  • Kovai Medical Center and Hospital Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Shilpa Medicare Limited

  • Dishman Carbogen Amcis Limited

  • Tarsons Products Limited

  • Sequent Scientific Limited

  • Wockhardt Limited

  • Hester Biosciences Limited

  • Morepen Laboratories Limited

  • Thyrocare Technologies Limited

  • Solara Active Pharma Sciences Limited

  • Krsnaa Diagnostics Limited

  • Supriya Lifescience Limited

  • Gufic Biosciences Limited

  • Themis Medicare Limited

  • Bliss GVS Pharma Limited

  • Suven Life Sciences Limited

  • Novartis India Limited

  • Lincoln Pharmaceuticals Limited

  • Shalby Limited

  • MEDICAMEN BIOTECH LIMITED

  • RPG Life Sciences Limited

  • Kopran Limited

  • Indraprastha Medical Corporation Limited

  • Bajaj Healthcare Limited

  • Syncom Formulations India Limited

  • Vimta Labs Limited

  • Jagsonpal Pharmaceuticals Limited

  • Gujarat Themis Biosyn Limited

  • KMC Speciality Hospitals (India) Limited

  • NGL Fine Chem Limited

  • Artemis Medicare Services Limited

  • Windlas Biotech Limited

  • SMS Pharmaceuticals Limited

  • Sigachi Industries Limited

  • Sastasundar Ventures Limited

  • Venus Remedies Limited

  • Fermenta Biotech Limited

  • Panacea Biotec Limited

  • Anuh Pharma Limited

  • Nectar Lifesciences Limited

  • Take Solutions Limited

  • Nureca Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Plastic Products

  • Trading

  • Chemicals

  • Finance - NBFC

  • IT - Software

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal S&P BSE Healthcare ETF

Scheme Analysis

Motilal Oswal S&P BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹6.05 crore. Motilal Oswal S&P BSE Healthcare ETF is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of Motilal Oswal S&P BSE Healthcare ETF ended up ₹0.17(0.72%)yesterday to ₹24.1283.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal S&P BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022-39804238
022-22816161